• In early March 2026, Veeco Instruments Inc. reported that a global leader in optical communications and laser manufacturing placed orders for multiple Lumina Metal Organic Chemical Vapor Deposition systems and Spector Ion Beam Sputtering Optical Coating systems to produce indium phosphide lasers for datacom applications.
• This order effectively designates Lumina as the customer’s production tool of record for InP epitaxy, underlining Veeco’s role in enabling optical transceivers that connect AI servers and support massive, low-latency data flows.
• Next, we’ll examine how securing InP laser production orders for AI datacom connectivity could influence Veeco’s existing investment narrative assumptions.

We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Veeco Instruments Investment Narrative Recap

To own Veeco, you generally have to believe that its tools will stay relevant as chipmaking and AI-related connectivity needs become more complex, and that management can convert that relevance into profitable growth over time. The new InP laser production order helps validate Veeco’s role in AI datacom, but it does not, by itself, resolve the most immediate concern around softer recent earnings and margin pressure, which still looks like the key near term swing factor.

Against that backdrop, Veeco’s full year 2026 guidance, issued just days before the InP announcement, may be the most directly relevant reference point. Management projected revenue of US$740 million to US$800 million and GAAP diluted EPS of US$0.83 to US$1.17, framing what expectations looked like before this new order. How investors reinterpret that guidance in light of fresh AI datacom demand, while still weighing execution and profitability risks, will be central to how the story evolves.

Yet behind the AI connectivity tailwind, investors should also weigh how concentrated customer orders could magnify the impact if spending patterns suddenly shift...

Veeco Instruments’ narrative projects $782.0 million revenue and $66.0 million earnings by 2028. This requires 3.7% yearly revenue growth and a $5.4 million earnings increase from $60.6 million today.

Uncover how Veeco Instruments' forecasts yield a $33.33 fair value, a 8% upside to its current price.

Exploring Other Perspectives

The most cautious analysts were assuming only about 4.4 percent annual revenue growth to roughly US$798 million by 2028 and earnings near US$66 million, so if you worry about customer concentration and tougher competitors, their more pessimistic story may feel closer to how you see Veeco today, even though this latest AI datacom order could eventually push expectations in a different direction.

Explore 3 other fair value estimates on Veeco Instruments - why the stock might be worth as much as 8% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Veeco Instruments research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Veeco Instruments research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Veeco Instruments' overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.